312 related articles for article (PubMed ID: 31928435)
1. Deficiency of Circulating Monocytes Ameliorates the Progression of Myxomatous Valve Degeneration in Marfan Syndrome.
Kim AJ; Xu N; Umeyama K; Hulin A; Ponny SR; Vagnozzi RJ; Green EA; Hanson P; McManus BM; Nagashima H; Yutzey KE
Circulation; 2020 Jan; 141(2):132-146. PubMed ID: 31928435
[TBL] [Abstract][Full Text] [Related]
2. Dynamic changes in mitral valve extracellular matrix, tissue mechanics and function in a mouse model of Marfan syndrome.
Gonzalez BA; Harmeyer SW; Song T; Sadayappan S; Yutzey KE
Matrix Biol; 2024 Feb; 126():1-13. PubMed ID: 38185344
[TBL] [Abstract][Full Text] [Related]
3. Loss of Axin2 results in impaired heart valve maturation and subsequent myxomatous valve disease.
Hulin A; Moore V; James JM; Yutzey KE
Cardiovasc Res; 2017 Jan; 113(1):40-51. PubMed ID: 28069701
[TBL] [Abstract][Full Text] [Related]
4. Macrophage Transitions in Heart Valve Development and Myxomatous Valve Disease.
Hulin A; Anstine LJ; Kim AJ; Potter SJ; DeFalco T; Lincoln J; Yutzey KE
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):636-644. PubMed ID: 29348122
[TBL] [Abstract][Full Text] [Related]
5. Wnt Signaling Inhibition Prevents Postnatal Inflammation and Disease Progression in Mouse Congenital Myxomatous Valve Disease.
Xu N; Alfieri CM; Yu Y; Guo M; Yutzey KE
Arterioscler Thromb Vasc Biol; 2024 Apr; ():. PubMed ID: 38660802
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic CCR2 Blockade Prevents Inflammation and Alleviates Myxomatous Valve Disease in Marfan Syndrome.
Xu N; Yutzey KE
JACC Basic Transl Sci; 2022 Nov; 7(11):1143-1157. PubMed ID: 36687269
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome.
Ng CM; Cheng A; Myers LA; Martinez-Murillo F; Jie C; Bedja D; Gabrielson KL; Hausladen JM; Mecham RP; Judge DP; Dietz HC
J Clin Invest; 2004 Dec; 114(11):1586-92. PubMed ID: 15546004
[TBL] [Abstract][Full Text] [Related]
8. Mitral valve disease in Marfan syndrome and related disorders.
Judge DP; Rouf R; Habashi J; Dietz HC
J Cardiovasc Transl Res; 2011 Dec; 4(6):741-7. PubMed ID: 21866385
[TBL] [Abstract][Full Text] [Related]
9. Smooth Muscle α-Actin Expression in Mitral Valve Interstitial Cells is Important for Mediating Extracellular Matrix Remodeling.
Dye BK; Butler C; Lincoln J
J Cardiovasc Dev Dis; 2020 Aug; 7(3):. PubMed ID: 32824919
[TBL] [Abstract][Full Text] [Related]
10. Autocrine serotonin and transforming growth factor beta 1 signaling mediates spontaneous myxomatous mitral valve disease.
Disatian S; Orton EC
J Heart Valve Dis; 2009 Jan; 18(1):44-51. PubMed ID: 19301552
[TBL] [Abstract][Full Text] [Related]
11. Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease.
Garcia-Pena A; Ibarrola J; Navarro A; Sadaba A; Tiraplegui C; Garaikoetxea M; Arrieta V; Matilla L; Fernández-Celis A; Sadaba R; Alvarez V; Gainza A; Jover E; López-Andrés N
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669101
[TBL] [Abstract][Full Text] [Related]
12. Structural and cellular changes in canine myxomatous mitral valve disease: an image analysis study.
Han RI; Black A; Culshaw G; French AT; Corcoran BM
J Heart Valve Dis; 2010 Jan; 19(1):60-70. PubMed ID: 20329491
[TBL] [Abstract][Full Text] [Related]
13. TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves.
Hagler MA; Hadley TM; Zhang H; Mehra K; Roos CM; Schaff HV; Suri RM; Miller JD
Cardiovasc Res; 2013 Jul; 99(1):175-84. PubMed ID: 23554457
[TBL] [Abstract][Full Text] [Related]
14. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
[TBL] [Abstract][Full Text] [Related]
15. Localized Antileptin Therapy Prevents Aortic Root Dilatation and Preserves Left Ventricular Systolic Function in a Murine Model of Marfan Syndrome.
Fisch S; Bachner-Hinenzon N; Ertracht O; Guo L; Arad Y; Ben-Zvi D; Liao R; Schneiderman J
J Am Heart Assoc; 2020 May; 9(10):e014761. PubMed ID: 32378446
[TBL] [Abstract][Full Text] [Related]
16. miR-29b participates in early aneurysm development in Marfan syndrome.
Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
[TBL] [Abstract][Full Text] [Related]
17. Macrophage lineages in heart valve development and disease.
Kim AJ; Xu N; Yutzey KE
Cardiovasc Res; 2021 Feb; 117(3):663-673. PubMed ID: 32170926
[TBL] [Abstract][Full Text] [Related]
18. Endothelial Cell Lineage Analysis Does Not Provide Evidence for EMT in Adult Valve Homeostasis and Disease.
Kim AJ; Alfieri CM; Yutzey KE
Anat Rec (Hoboken); 2019 Jan; 302(1):125-135. PubMed ID: 30306735
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of aortic wall complications in Marfan syndrome.
Grewal N; Gittenberger-de Groot AC
Cardiovasc Pathol; 2018; 33():62-69. PubMed ID: 29433109
[TBL] [Abstract][Full Text] [Related]
20. Multi-scale biomechanical remodeling in aging and genetic mutant murine mitral valve leaflets: insights into Marfan syndrome.
Gould RA; Sinha R; Aziz H; Rouf R; Dietz HC; Judge DP; Butcher J
PLoS One; 2012; 7(9):e44639. PubMed ID: 22984535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
